Cartridge-based nucleic acid amplification test useful for early diagnosis of extrapulmonary tuberculosis
According to a study published in JAPI, Journal of the Association of Physicians of India, researchers have concluded that a Cartridge-based nucleic acid amplification test can rapidly diagnose highly infectious diseases like MTB within 2 hours. It is vital to initiate the treatment fast to prevent the development of resistant cases.
This study entitled “Diagnostic Approach to Extrapulmonary Tuberculosis by Cartridge-based Nucleic Acid Amplification Test” is led by Saswati Chattopadhyay and colleagues.
The team said tuberculosis (TB) is a highly infectious disease affecting millions worldwide. Pulmonary TB is the most common. Extrapulmonary cases are also very rampant and are responsible for a huge number of cases. It is challenging to diagnose extrapulmonary cases because of varied manifestations and infections paucibacillary nature.
Cartridge-based nucleic acid amplification test (CBNAAT) is simple and rapid.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.